I am a radiochemist specializing in the synthesis, characterization, and application of radiopharmaceuticals for diagnostic imaging and therapeutic use. My expertise includes radiolabeling of small molecules, peptides, and biomolecules with a variety of isotopes, such as F-18, C-11, Ga-68, and Tc-99m, ensuring high radiochemical purity and specific activity.

I have extensive experience in developing and optimizing automated synthesis protocols, including cyclotron operation and maintenance. My skill set includes quality control (QC) testing using advanced analytical techniques such as HPLC, GC, and radio-TLC, as well as compliance with Good Manufacturing Practices (GMP) for radiopharmaceutical production.

In addition to radiochemistry, I have a strong background in pharmacokinetics, biodistribution studies, and imaging modalities such as PET and SPECT. I collaborate with multidisciplinary teams to advance novel tracers from preclinical evaluation to clinical trials, supporting translational research and regulatory submissions.

Passionate about leveraging radiochemistry to enhance precision medicine, I am committed to driving innovation in molecular imaging and targeted radiotherapies.